These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 9859960)

  • 1. Time course of antibody response to tetanus toxoid and pneumococcal capsular polysaccharides in patients infected with HIV.
    Talesnik E; Vial PA; Labarca J; Méndez C; Soza X
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):471-7. PubMed ID: 9859960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG2 subclass restriction of antibody to pneumococcal polysaccharides.
    Barrett DJ; Ayoub EM
    Clin Exp Immunol; 1986 Jan; 63(1):127-34. PubMed ID: 3955880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patients.
    Opravil M; Fierz W; Matter L; Blaser J; Lüthy R
    Clin Exp Immunol; 1991 May; 84(2):185-9. PubMed ID: 2025948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes.
    Kroon FP; van Dissel JT; de Jong JC; van Furth R
    AIDS; 1994 Apr; 8(4):469-76. PubMed ID: 7912086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies against pneumococcal polysaccharides after vaccination in HIV-infected individuals: 5-year follow-up of antibody concentrations.
    Kroon FP; van Dissel JT; Ravensbergen E; Nibbering PH; van Furth R
    Vaccine; 1999 Oct; 18(5-6):524-30. PubMed ID: 10519943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of specific immunoglobulin G (IgG) and its subclasses (IgG1 and IgG2) against the 23-valent pneumococcal vaccine in a healthy adult population: proposal for response criteria.
    Rodrigo MJ; Miravitlles M; Cruz MJ; de Gracia J; Vendrell M; Pascual C; Morell F
    Clin Diagn Lab Immunol; 1997 Mar; 4(2):168-72. PubMed ID: 9067650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of recent human immunodeficiency virus seroconverters to the pneumococcal polysaccharide vaccine and Haemophilus influenzae type b conjugate vaccine.
    Weiss PJ; Wallace MR; Oldfield EC; O'Brien J; Janoff EN
    J Infect Dis; 1995 May; 171(5):1217-22. PubMed ID: 7751696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired anti-pneumococcal antibody response in patients with AIDS-related persistent generalized lymphadenopathy.
    Ballet JJ; Sulcebe G; Couderc LJ; Danon F; Rabian C; Lathrop M; Clauvel JP; Seligmann M
    Clin Exp Immunol; 1987 Jun; 68(3):479-87. PubMed ID: 3652522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines.
    Soininen A; Seppälä I; Nieminen T; Eskola J; Käyhty H
    Vaccine; 1999 Apr; 17(15-16):1889-97. PubMed ID: 10217586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isotypes and opsonophagocytosis of pneumococcus type 6B antibodies elicited in infants and adults by an experimental pneumococcus type 6B-tetanus toxoid vaccine.
    Vidarsson G; Sigurdardottir ST; Gudnason T; Kjartansson S; Kristinsson KG; Ingolfsdottir G; Jonsson S; Valdimarsson H; Schiffman G; Schneerson R; Jonsdottir I
    Infect Immun; 1998 Jun; 66(6):2866-70. PubMed ID: 9596761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus-infected subjects: persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response.
    Rodriguez-Barradas MC; Groover JE; Lacke CE; Gump DW; Lahart CJ; Pandey JP; Musher DM
    J Infect Dis; 1996 Jun; 173(6):1347-53. PubMed ID: 8648206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective antipneumococcal polysaccharide antibody response in children with recurrent respiratory tract infections.
    Sanders LA; Rijkers GT; Kuis W; Tenbergen-Meekes AJ; de Graeff-Meeder BR; Hiemstra I; Zegers BJ
    J Allergy Clin Immunol; 1993 Jan; 91(1 Pt 1):110-9. PubMed ID: 8423268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody class and subclass responses to pneumococcal polysaccharides following immunization of human immunodeficiency virus-infected patients.
    Carson PJ; Schut RL; Simpson ML; O'Brien J; Janoff EN
    J Infect Dis; 1995 Aug; 172(2):340-5. PubMed ID: 7622875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The acquisition of anti-pneumococcal capsular polysaccharide Haemophilus influenzae type b and tetanus toxoid antibodies, with age, in the UK.
    Hazlewood M; Nusrat R; Kumararatne DS; Goodall M; Raykundalia C; Wang DG; Joyce HJ; Milford-Ward A; Forte M; Pahor A
    Clin Exp Immunol; 1993 Aug; 93(2):157-64. PubMed ID: 8348740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigens.
    Dagan R; Melamed R; Zamir O; Leroy O
    Pediatr Infect Dis J; 1997 Nov; 16(11):1053-9. PubMed ID: 9384339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of human immunodeficiency virus infection on the IgA and IgG antibody responses to pneumococcal vaccine.
    Mascart-Lemone F; Gérard M; Libin M; Crusiaux A; Franchioly P; Lambrechts A; Goldman M; Clumeck N
    J Infect Dis; 1995 Nov; 172(5):1253-60. PubMed ID: 7594661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin G class and subclass antibodies to pneumococcal capsular polysaccharides.
    Chudwin DS; Artrip SG; Schiffman G
    Clin Immunol Immunopathol; 1987 Jul; 44(1):114-21. PubMed ID: 3297436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro humoral immunity in surgical patients: antibody response to pneumococcal polysaccharide.
    Nohr CW; Latter DA; Meakins JL; Christou NV
    Surgery; 1986 Aug; 100(2):229-38. PubMed ID: 3488597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of IgG2 Antibodies to Pneumococcal Polysaccharides After Vaccination of Treated HIV Patients May Be Augmented by IL-7Rα Signaling in ICOS
    Abudulai LN; Fernandez S; Corscadden K; Kirkham LA; Hunter M; Post JJ; French MA
    Front Immunol; 2019; 10():839. PubMed ID: 31068934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adults.
    Schauer U; Stemberg F; Rieger CH; Büttner W; Borte M; Schubert S; Möllers H; Riedel F; Herz U; Renz H; Herzog W
    Clin Diagn Lab Immunol; 2003 Mar; 10(2):202-7. PubMed ID: 12626443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.